TGA Approval

Revefore NMN 18000 (466306)

ARTG ID

466306

ARTG Name

Revefore NMN 18000

Sponsor

Walve Biotech Pty Ltd

ARTG Date

October 29, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Listed - Exempt

Sponsor Information

Sponsor Name

Sponsor Item Name

WALVE BIOTECH PTY LTD

Ingredient Name

nicotinamide mononucleotide

Empowering clinical research with data-driven insights and AI-powered tools.

Revefore NMN 18000 (466306) - TGA 批准文号 | MedPath